‘Israel's largest healthcare provider on Sunday (Oct 14) reported a 94 per cent drop in symptomatic COVID-19 infections among 600,000 people who received two doses of the Pfizer's vaccine in the country's biggest study to date.
‘Health maintenance organization (HMO) Clalit, which covers more than half of all Israelis, said the same group was also 92 per cent less likely to develop severe illness from the virus.’
Read here (Channel News Asia, Feb 15, 2021)
